BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15717752)

  • 21. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers.
    Harada K; Yasoshima M; Ozaki S; Sanzen T; Nakanuma Y
    J Pathol; 2001 Feb; 193(2):210-7. PubMed ID: 11180168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pitfalls in TRAP assay in routine detection of malignancy in effusions.
    Braunschweig R; Guilleret I; Delacrétaz F; Bosman FT; Mihaescu A; Benhattar J
    Diagn Cytopathol; 2001 Oct; 25(4):225-30. PubMed ID: 11599105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
    Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
    J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
    Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
    Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
    Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
    Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of human telomerase reverse transcriptase by in situ hybridization in lung carcinoma.
    Fukushima M; Shimomura N; Nakamura K; Kammori M; Koizumi K; Shimizu K; Takubo K
    Oncol Rep; 2004 Dec; 12(6):1227-32. PubMed ID: 15547742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
    Lee WY
    Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (Sure Path) in evaluation of serous effusion fluids.
    Dadhich H; Toi PC; Siddaraju N; Sevvanthi K
    Diagn Cytopathol; 2016 Nov; 44(11):874-879. PubMed ID: 27546351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase in (pre)neoplastic cervical disease.
    Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
    Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The negative enrichment by immunomagnetic beads for tumor cells from malignant pleural effusions].
    Yang JJ; Xu XX; Min LF; Lin P; Qian GS
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):673-8. PubMed ID: 23158070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of efficacy of cell block versus conventional smear study in exudative fluids.
    Matreja SS; Malukani K; Nandedkar SS; Varma AV; Saxena A; Ajmera A
    Niger Postgrad Med J; 2017; 24(4):245-249. PubMed ID: 29355165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
    Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
    Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8.
    Wakely PE; Menezes G; Nuovo GJ
    Mod Pathol; 2002 Sep; 15(9):944-50. PubMed ID: 12218212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
    Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
    Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of assay of human telomerase reverse transcriptase mRNA and cytology using bile obtained by endoscopic transpapillary catheterization into the gallbladder for diagnosis of gallbladder carcinoma.
    Uchida N; Tsutsui K; Ezaki T; Fukuma H; Kobara H; Kamata H; Aritomo Y; Masaki T; Watanabe S; Kobayashi S; Nakatsu T; Nakano H; Kuriyama S
    Am J Gastroenterol; 2003 Nov; 98(11):2415-9. PubMed ID: 14638342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumours by in situ hybridization with a new oligonucleotide probe.
    Kammori M; Nakamura K; Ogawa T; Mafune K; Tatutomi Y; Obara T; Onoda N; Fujiwara M; Izumiyama-Shimomura N; Mori M; Kaminishi M; Takubo K
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):43-8. PubMed ID: 12519411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme.
    Falchetti ML; Pallini R; D'Ambrosio E; Pierconti F; Martini M; Cimino-Reale G; Verna R; Maira G; Larocca LM
    Int J Cancer; 2000 Dec; 88(6):895-901. PubMed ID: 11093811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.